Rockwell Medical Technologies (RMTI) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $6.10 +8.93%
EPS Growth %: -200.0%
Financial Fact:
Cost of Sales: 11.23M
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: -200.0%
Financial Fact:
Cost of Sales: 11.23M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Rockwell Medical Technologies (NASDAQ: RMTI) reported Q3 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $12.8 million versus the consensus estimate of $15.4 million.
For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
- TRNR agrees to acquire STEPR, raises 2026 revenue guidance to $50M
- ExxonMobil outlines key factors for Q2 2026 earnings outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
